Avalo Therapeutics (AVTX) Prepaid Assets (2014 - 2026)

Avalo Therapeutics has reported Prepaid Assets for 13 years, with the latest figure at $6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 264.7% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (up 264.7% YoY), and the FY2025 full-year result was $6.9 million, up 59.84% from the prior year.
• Prepaid Assets for Q1 2026 stood at $6.7 million, down from $6.9 million in the prior quarter.
• The five-year high for Prepaid Assets was $6.9 million in Q4 2025, with the low at $100000.0 in Q1 2024.
• Historically, Prepaid Assets has averaged $2.1 million across 5 years, with a median of $1.6 million in 2023.
• Annual changes were most pronounced in 2024 — Prepaid Assets plunged 93.85% — and 2025, when it soared 1803.0%.
• Avalo Therapeutics' Prepaid Assets stood at $1.3 million in 2022, then slumped by 61.24% to $500000.0 in 2023, then soared by 765.0% to $4.3 million in 2024, then jumped by 59.84% to $6.9 million in 2025, then decreased by 3.3% to $6.7 million in 2026.
• The last three Prepaid Assets figures came in at $6.7 million (Q1 2026), $6.9 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.